Context: Corona pandemic is on the wane in India: The downward trend in fresh coronavirus infections in India continues to inspire confidence that the pandemic is on the wane. The daily new cases fell below 10,000 for the third time this month. India’s tally is now 10.9 million cases and fresh reported fatalities …
Context: Any vaccine against COVID-19 should be granted emergency use authorisation only after proper consideration and conducting its trials on a sufficient sample size, a parliamentary panel has recommended to the government. In a report submitted to Rajya Sabha chairman and vice-president, the Parliamentary Standing Committee on Home Affairs also said there was a …
Context: Union Health Minister, on multiple occasions has said that an India-made vaccine was likely to be available in “early 2021”. The government already has an expert committee on vaccine distribution. With over 6 million cases and the death toll from COVID-19 approaching 100,000, India is entering the first winter of the pandemic. Viral …
Continue reading “Insights into Editorial: Weighing the costs: On COVID-19 vaccine”
Topics Covered: Science and Technology- developments and their applications and effects in everyday life Achievements of Indians in science & technology; indigenization of technology and developing new technology. What is Oxford university’s ChAdOx1 Covid-19 vaccine? ChAdOx1 COVID-9 was jointly developed by British-Swedish company AstraZeneca and the University of Oxford. It has been found to be safe and …
Continue reading “What is Oxford university’s ChAdOx1 Covid-19 vaccine?”
Topics Covered: Issues related to health. What is Vaccine Nationalism? The Context: The United States has now twice indicated that it would like to secure priority access to doses of COVID-19 vaccine. Other countries, including India and Russia, have taken similar stances. This prioritisation of domestic markets has become known as vaccine nationalism. How it works? …
